Oligonucleotide CDMO Market to Hit US$6.73 Billion by 2029 with 21.8% CAGR | MarketsandMarkets™
The globalOligonucleotide CDMO Market, valued at US$2.33 billion in 2023, is forecasted to grow at a robust CAGR of 21.8%, reaching US$2.51 billion in 2024 and an impressive US$6.73 billion by 2029. Rising outsourcing of development and manufacturing to CDMOs and growing focus on precision/personalized medicine are some of the factors driving the market's growth. […]